Results 81 to 90 of about 1,816 (199)

Drug Delivery Innovation during Cataract Surgery: Are We Ready for Dropless Cataract Surgery?

Delhi Journal of Ophthalmology, 2019
At present, drug administration options during cataract surgery include topical application. Subconjunctival application is not used now. Intracameral Injection is reserved for antibiotic supplement.
Suresh K. Pandey, Vidushi Sharma
doaj   +1 more source

Fluocinolone Acetonide Implant Injected 1 Month after Dexamethasone Implant for Diabetic Macular Oedema: the ILUVI1MOIS Study

Ophthalmology and Therapy, 2023
Introduction The aim of this study was to assess the efficacy and safety of fluocinolone acetonide implant (FAci) injected 1 month after the last dexamethasone intravitreal implant (DEXi) in chronic diabetic macular oedema (DME) patients.
Nicolas Rousseau, Olivier Lebreton, Hélène Masse, Yann Maucourant, Valentin Pipelart, Manon Clement, Marie-Laure Le Lez, Raoul Kanav Khanna, Maxime Pepin, Yannick Eude, Guylène Le Meur, Michel Weber, Jean-Baptiste Ducloyer   +12 more
doaj   +1 more source

Design of an Implantable Device for Ocular Drug Delivery [PDF]

, 2012
Ocular diseases, such as, glaucoma, age-related macular degeneration (AMD), diabetic retinopathy, and retinitis pigmentosa require drug management in order to prevent blindness and affecting million of adults in USA and worldwide.
Atkinson, Gary M., Lee, Jae Hwan, Moorthy, Ramana S., Pidiparti, Ramana M.   +3 more
core   +3 more sources

Keratoprosthesis, silicone oil placement, and fluocinolone acetonide implant for treatment of uveitis-associated hypotony and keratopathy

Journal of Ophthalmic Inflammation and Infection, 2022
Purpose To describe a case series of combined Boston Type 1 Keratoprosthesis with pars plana vitrectomy, silicone oil placement, and fluocinolone acetonide intravitreal 0.59 mg implant (RETISERT®), and report its safety and efficacy in preventing ...
Arman Mosenia, Miel Sundararajan, Jay M. Stewart, Julie M. Schallhorn   +3 more
doaj   +1 more source

Efficacy and safety of different doses of a slow-release corticosteroid implant for macular edema [Corrigendum]

Drug Design, Development and Therapy, 2016
Liu QY, He MM, Shi H, et al. Drug Des Devel Ther. 2015;9: 2527–2535. In “Efficacy and safety of different doses of a slow release corticosteroid implant for macular edema: meta-analysis of randomized controlled trials” published ...
Liu QY, He MM, Shi H, Wang QY, Du YR, Liu JL, Ren CD, Xu D, Yu J   +8 more
doaj  

Ahmed glaucoma valve in uveitic patients with fluocinolone acetonide implant-induced glaucoma: 3-year follow-up

Clinical Ophthalmology, 2018
Buraa Kubaisi,1,2 Arash Maleki,1,2 Aseef Ahmed,1,2 Neel Lamba,1,2 Haitham Sahawneh,1,2 Andrew Stephenson,1,2 Alyssa Montieth,1,2 Shobha Topgi,3 C Stephen Foster1,2,4 1Massachusetts Eye Research and Surgery Institution, Waltham, MA, USA; 2Ocular ...
Kubaisi B, Maleki A, Ahmed A, Lamba N, Sahawneh H, Stephenson A, Montieth A, Topgi S, Foster CS   +8 more
doaj  

Efficacy and safety of sustained-delivery fluocinolone acetonide intravitreal implant in patients with chronic diabetic macular edema insufficiently responsive to available therapies: a real-life study

Clinical Ophthalmology, 2016
Pascale Massin, Ali Erginay, Bénédicte Dupas, Aude Couturier, Ramin Tadayoni Ophthalmology Department, Lariboisière Hospital, Paris, France Purpose: To evaluate the efficacy and safety of sustained-delivery fluocinolone acetonide ...
Massin P, Erginay A, Dupas B, Couturier A, Tadayoni R   +4 more
doaj  

Morphological assessment of the retina in uveitis [PDF]

, 2016
BACKGROUND: The objective of this study is to describe a system for color photograph evaluation in uveitis and report baseline morphologic findings for the Multicenter Uveitis Steroid Treatment (MUST) Trial. Four-hundred seventy-nine eyes of 255 subjects
Altaweel, Michael M, Dunn, James P, Elner, Susan G, Gangaputra, Sapna S, Jaffe, Glenn J, Kempen, John H, Kim, Rosa Y, MUST Research Group,, Rao, P. Kumar, Reed, Susan B, Thorne, Jennifer E   +10 more
core   +3 more sources

Scleral melt following Retisert intravitreal fluocinolone implant

Drug Design, Development and Therapy, 2014
Ilias Georgalas,1 Chrysanthi Koutsandrea,1 Dimitrios Papaconstantinou,1 Dimitrios Mpouritis,1 Petros Petrou1,2 1Ophthalmology Department, University of Athens, Athens, Greece; 2Moorfields Eye Hospital, London, UKAbstract: Intravitreal fluocinolone ...
Georgalas I, Koutsandrea C, Papaconstantinou D, Mpouritis D, Petrou P   +4 more
doaj  

Real-World Outcomes in Diabetic Macular Edema for the 0.2 μg/Day Fluocinolone Acetonide Implant: Case Series from the Midlands, UK

Clinical Ophthalmology, 2021
Bushra Mushtaq,1 Ajay Bhatnagar,2 Helen Palmer3 1Birmingham Midland Eye Centre, City Hospital SWBH NHS Trust, Birmingham, UK; 2Department of Ophthalmology, New Cross Hospital, The Royal Wolverhampton NHS Trust, Wolverhampton, UK; 3Ophthalmology ...
Mushtaq B, Bhatnagar A, Palmer H
doaj